Coleman, M. F., McDonell, S. B., Eisenbeis, L. K., Devericks, E. N., Chandi, J., Dave, O., . . . Teegarden, D. (2025). The nonsteroidal anti-inflammatory drug sulindac reverses obesity-driven immunosuppression and triple-negative breast cancer progression. Breast Cancer Research, 27(1), 1-17.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Coleman, Michael F., et al. "The Nonsteroidal Anti-inflammatory Drug Sulindac Reverses Obesity-driven Immunosuppression and Triple-negative Breast Cancer Progression."
Breast Cancer Research 27, no. 1 (2025): 1-17.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Coleman, Michael F., et al. "The Nonsteroidal Anti-inflammatory Drug Sulindac Reverses Obesity-driven Immunosuppression and Triple-negative Breast Cancer Progression."
Breast Cancer Research, vol. 27, no. 1, 2025, pp. 1-17.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.